CLINICAL_TRIALS
trial_result
· 2022-06-13
Clinical Trial Update: IV Dexmedetomidine in the Duration of Spinal Anesthesia With Hyperbaric Bupivacaine: Double Blind Randomized Trial. [Phase 3]
Summary
A phase 3 randomized, double-blind trial evaluating intravenous dexmedetomidine for duration of spinal anesthesia with hyperbaric bupivacaine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital Central "Dr. Ignacio Morones Prieto" | Conditions: Anesthesia, Dexmedetomidine | Phase 3 | Status: UNKNOWN